Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Size to Grow by USD 106.84 Million at a CAGR of 8.12% from 2022 to 2027 – The rising demand for drug delivery applications to drive the market growth – Technavio

NEW YORK, Dec. 6, 2023 /PRNewswire/ — The poly (lactic-co-glycolic acid) (PLGA) market is projected to increase at a CAGR of 8.12% during the forecast period – 2022 to 2027 by Technavio data analysts and research experts. This market research report also suggests statistics about the market size that will grow by USD 106.84 million. The rising demand for drug delivery applications, the growing number of surgical advancements, and the rising number of traumatic injuries caused by the increasing road accidents are projected as the key factors leading to the poly (lactic-co-glycolic acid) (PLGA) market share growth.


Technavio has announced its latest market research report titled Global Poly(Lactic-Co-Glycolic Acid) (PLGA) Market 2023-2027

For more such market analysis updates, historic (2017 to 2021), and forecast market size (2023 to 2027), request for the sample PDF report.

New Business Opportunities – Market Segments and Key Regions Analysis

As per Technavio’s analysis, there are several market segments classified including personal care and dermatology, suture, fracture fixation, and others in the poly (Lactic-Co-Glycolic Acid) (PLGA) market.

Among all these market segments, the personal care and dermatology segment is projected to record the highest market share growth during the forecast period. It was valued at USD 68.81 million in 2017 and continued to grow significantly by 2021.

Considering the geographical regions for market share growth, North America is projected at top of the list. 35% of the total market share growth will originate from North America by 2027.

Technavio further suggests, cost-effectiveness and the unique functional properties of PLGA and regulatory approval for several PLGA products by government agencies and international regulations support the poly lactic-co-glycolic acid market growth in North America during the forecast period.

For more detailed segment analysis and geographical business distribution, historic (2017 to 2021), and forecast market size (2023 to 2027), get the exclusive sample PDF report.

Key Market Driver, Trend, and Challenge

The rising demand for drug delivery applications is significantly driving the Poly (Lactic-Co-Glycolic Acid) (PLGA) market growth.

Technavio also suggests, growing demand for electrospinning and 3D printing technologies will emerge as a primary market trend for growth in the Poly (Lactic-Co-Glycolic Acid) (PLGA) market from 2022 to 2027.

As an emerging market challenge, high prices of the PLGA may impede market growth as per Technavio’s report.

What`s New?

  • Special coverage on the RussiaUkraine war; global inflation; recovery analysis from COVID-19; supply chain disruptions, global trade tensions; and risk of recession
  • Global competitiveness and key competitor positions

Market presence across multiple geographical footprints – Strong/Active/Niche/Trivial – buy the full report.

Key Market Vendors

There are a few key vendors operating in the market, mentioned in the report such as:

  • Akina Inc.
  • Foster Corp.
  • Ashland Inc.
  • Huizhou Foryou Medical Devices Co. Ltd.
  • CD Bioparticles
  • Corbion NV
  • Creative PEGWorks
  • Alfa Chemistry
  • Evonik Industries AG

Avail Technavio’s subscription to get lifetime access to 17,000+ market reports and world-class market intelligence.

Key Data Covered in this Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Report

  • Projected CAGR of the market during 2023-2027
  • Detailed statistical information on the major market drivers of the Poly (Lactic-Co-Glycolic Acid) (PLGA) market during 2023-2027
  • Market size analysis of the Poly (Lactic-Co-Glycolic Acid) (PLGA) market size and its association with the parent market
  • Relevant predictions about upcoming market trends and detailed consumer behavior analysis
  • Market share growth analysis across North America, APAC, Europe, South America, and the Middle East and Africa
  • Detailed market’s competitive landscape and key information about market vendors
  • Comprehensive analysis of various market challenges

Related Reports

  • The multiple myeloma drugs market is projected to increase at a CAGR of 5.9% during the forecast period – 2022 to 2027 by Technavio data analysts and research experts. This market research report also suggests the statistics about the market size that will grow by USD 6,419.94 million.
  • The generic drugs market is projected to increase at a CAGR of 7.11% during the forecast period – 2022 to 2027 by Technavio data analysts and research experts. This market research report also suggests statistics about the market size that will grow by USD 176.25 billion.

About US

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/poly-lactic-co-glycolic-acid-plga-market-size-to-grow-by-usd-106-84-million-at-a-cagr-of-8-12-from-2022-to-2027–the-rising-demand-for-drug-delivery-applications-to-drive-the-market-growth–technavio-302006919.html

SOURCE Technavio